International Journal of Pediatric Otorhinolaryngology
Cochlear involvement in Familial Mediterranean Fever: A new feature of an old disease
Introduction
Familial Mediterranean Fever (FMF) is an auto-inflamatory disease of serous membranes characterized by recurrent attacks of fever, abdominal, articular and thoracic pain. The disease is an autosomal recessively inherited genetic disease that affects Turks, Arabs, Sephardic Jews and Armenians [1], [2]. The symptoms are seen by the age of ten in 60% of the cases and by 20 in 90% [3]. Amyloidosis is one of the most frequent comlications and the disease involves many organs as kidneys, central nervous system, heart, respiratory and gastrointestinal tracts [4]. In recent years it was seen that FMF patients have increased risk of acquiring vasculitic diseases such as polyarteritisnodosa, Behcet's disease, diverse glomerulopathies and HenochSchonlein Purpura [5]. A rate of 8% of such vasculitic diseases was reported in a series of 207 FMF patients [6].
The diagnosis of the disease remains to be clinical since there are not specific laboratory tests for definitive diagnosis yet. One of the commonly used criterias for diagnosis is Tel Hashomer criteria. Livneh [7] proposed a new diagnostic criteria in 1997 including vasculitis, and then Yalcinkaya et al. [8] also proposed another one including elevated CRP and ESR levels. Because of the absence of exceedingly specific diagnostic tests for FMF and low index of suspicion, the diagnosis usually comes quite later than the first symptom. Therefore, it is mandatory to enlighten all of the characteristics of the disease that may add to the present diagnostic criteria and to provide an opportunity for better understanding of its nature.
Since vasculitic diseases and amyloidosis are seen frequently during the course of FMF and the disease involves many organs as kidneys, central nervous system, heart, respiratory and gastrointestinal tracts by amyloidosis or vasculitis, cochleovestibular involvement related to the course of the disease is probable [4], [5]. To our knowledge, otological involvement in FMF has not been studied until now. In this study we aimed to investigate the cochlear functions in children with FMF using audiometry and otoaoustic emissions (OAE). Additionally, the correlation between the hearing levels and some clinical features of FMF including duration of the disease, age at onset, genetic analysis and colchicine use were planned to be studied.
Section snippets
Patients
This study was conducted after getting IRB approval. The patients with definitive diagnosis of FMF (n = 34) according to Tel Hashomer criteria and healthy controls that admitted to the clinic for nonspecific symptoms (n = 27). Informed consents were obtained from parents and the children if feasible. All patients had genetic analysis performed for the most common mutations (M694V, M680I, M694I, V726A, E148Q, R202Q, F479L, A744S) in our country.
Clinical and laboratory evaluation
Both the patients and the controls were evaluated in
Demographic data
The study group comprised of 34 children (17 males and 17 females) with a mean age of 12.1 years (range 5.2–18.5). The control group composed of 27 children (8 males and 19 females) with a mean age of 11.4 years (range 4.2–17.4). The age (p = 0.552) and sex distribution (p = 0.125) was not significantly different between the two groups. Table 1 summarizes clinical presentations of the children with FMF. The detected mutations were read from the charts and shown in Table 2.
Audiologic data
Two children from the
Discussion
Our results clearly show a cochlear involvement in FMF demonstrated by both audiometry and DPOAE. Audiological findings revealed lower DP and SNR values on DPOAE testing together with higher hearing levels at high frequencies in children with FMF. PTA levels were not in the level of hearing loss and were not different in both groups. Additionally, we showed that the age of disease onset has a significant impact on the cochlear involvement.
FMF is a childhood disease and cochlear functions are
Conclusion
To our knowledge, our study demonstrating cochlear involvement in FMF patients in pediatric age group is the first in medical literature. Similar studies must be carried out in adult patients to see if a clinical hearing loss develops or not. The possible mechanisms that cause cochlear involvement and the effect of colchicine treatment on the cochlea must be enlightened.
References (26)
- et al.
Familial Mediterranean Fever. A survey of 470 cases and review of the literature
Am. J. Med.
(1967) - et al.
Inner ear involvement in Behcet's disease
Auris Nasus Larynx
(2010) - et al.
Prevalence and significance of MEFV gene mutations in a cohort of patients with rheumatoid arthritis
Joint Bone Spine
(2010) - et al.
Colchicine in the treatment of AA and AL amyloidosis
Semin. Arthritis Rheum.
(1993) - et al.
Familial Mediterranean Fever
AMA Arch. Intern. Med.
(1958) - et al.
Ailevî Akdeniz ateşinin demografik, klinik ve genetik özellikleri ile tedaviye yanıtı: 120 vakalık tek merkez deneyimi
Çocuk Sağlığı ve Hastalıkları Dergisi
(2006) - et al.
Renal amyloidosis in children
Pediatr. Nephrol.
(2011) Familial Mediterranean Fever: a continuously challenging disease
Isr. Med. Assoc. J.
(2011)- et al.
Vasculitis in Familial Mediterranean Fever
J. Rheumatol.
(1997) - et al.
Criteria for the diagnosis of Familial Mediterranean Fever
Arthritis Rheum.
(1997)
A new set of criteria for the diagnosis of familial Mediterranean fever in childhood
Rheumatology (Oxford)
Clinical, laboratory and molecular characteristics of children with Familial Mediterranean Fever-associated vasculitis
Acta Paediatr.
Vasculitis in siblings with Familial Mediterranean Fever: a report of three cases and review of the literature
Clin. Rheumatol.
Cited by (14)
Evaluation of hearing in familial Mediterranean fever children
2023, Egyptian RheumatologistCitation Excerpt :Lordoglu et al. [17] also showed that the mean PTA increased significantly (worse hearing) at 500, 4000, and 8000 Hz frequencies. Furthermore, Koybasi et al. [18] also showed that the mean hearing thresholds at frequencies of 8000, 10,000, 12,500, and 16,000 Hz elevated substantially. On the other hand, others found that PTA outcomes were within the normal range with a normal inner ear function [19–21].
Effects of familial Mediterranean fever on the middle ear
2020, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :Cohen's d and r were interpreted as small (0.29–0.49 and 0.10–0.24, respectively), medium (0.50–0.79 and 0.25–0.39, respectively), or large (≥0.80 and ≥ 0.40, respectively) effect sizes [24]. Because previous studies did not reveal a precise effect size, the minimum sample size was determined by calculating the arithmetic mean of the sample sizes of these studies [2–7]. The sample size was also checked by calculating the effect size of the significant statistical results [24] and considered as acceptable if the size was not small.
Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period
2019, International Journal of Pediatric OtorhinolaryngologyEvaluation of cochlear functions in children with Familial Mediterranean Fever
2016, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :According to disease severity score developed by Pras et al.; 16% (n = 8) patients were placed in the mild group, 72% (n = 36) were placed in moderate group, and 12%(n = 6) were placed in severe group. Patients had a median disease severity score of 7 [4–10]. The audiogram data were analyzed separately for the right and the left ear in both groups.
Cochlear functions in children with familial Mediterranean fever: Any role of the severity of the disease?
2015, International Journal of Pediatric OtorhinolaryngologyDetermination of hearing levels in patients with Familial Mediterranean Fever
2013, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :Authors reported that there was cochlear involvement in HFA and DPOEA tests, although PTA findings were normal in patients with FMF [9]. They also reported that hearing thresholds in higher frequencies were elevated in audiometric evaluations and there were decreased distortion products and signal–noise ratios demonstrated by distortion product otoacoustic emission testing [9]. Again, authors suggested that age at the onset of the diseases is an important factor in the involvement of hearing [9].